Monte Rosa Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $35M | 6.6M | 5.30 |
| 2024-06-30 | $22M | 6.0M | 3.75 |
| 2024-03-31 | $36M | 5.1M | 7.05 |
| 2023-12-31 | $28M | 4.9M | 5.65 |
| 2023-09-30 | $19M | 3.9M | 4.79 |
| 2023-06-30 | $27M | 3.9M | 6.85 |
| 2023-03-31 | $29M | 3.7M | 7.79 |
| 2022-12-31 | $28M | 3.7M | 7.61 |
| 2022-03-31 | $75M | 5.4M | 14.02 |
| 2021-12-31 | $85M | 4.1M | 20.42 |
| 2021-09-30 | $69M | 3.1M | 22.01 |
| 2021-06-30 | $61M | 2.7M | 22.38 |